TickerFacts.

Akari Therapeutics Plc (AKTX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2018-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$21.63M
Year ended 2024-12-31
2014-12-31: -$1.91M2015-12-31: -$30.57M2016-12-31: -$27.21M2017-12-31: -$37.74M2018-12-31: -$20.75M2019-12-31: -$16.94M2020-12-31: -$17.97M2021-12-31: -$17.21M2022-12-31: -$23.08M2023-12-31: -$16.80M2024-12-31: -$21.63M-$21.63M
2014-12-31 EBITDA (USD) 2024-12-31
Period endedEBITDAChange YoYSource filing
2024-12-31-$21.63Mn/m2026-03-30, From 2024-01-01
2023-12-31-$16.80Mn/m2025-04-15, From 2023-01-01
2022-12-31-$23.08Mn/c2024-03-29, From 2022-01-01
2021-12-31-$17.21Mn/m2023-05-01, From 2021-01-01
2020-12-31-$17.97Mn/m2023-05-01, From 2020-01-01
2019-12-31-$16.94Mn/m2022-05-16, From 2019-01-01
2018-12-31-$20.75Mn/c2021-04-21, From 2018-01-01
2017-12-31-$37.74Mn/m2020-03-31, From 2017-01-01
2016-12-31-$27.21Mn/m2019-04-23, From 2016-01-01
2015-12-31-$30.57Mn/m2018-07-18, From 2015-01-01
2014-12-31-$1.91Mn/a2017-03-31, From 2014-01-01